Short- and long-term phasing of intraocular pressure in stable and progressive glaucoma

Ophthalmologica

Volumn 230, Issue 2, 2013, Pages 87-92

  Fogagnolo, Paolo ^a   Orzalesi, Nicola ^a   Centofanti, Marco ^b,c   Oddone, Francesco ^b   Manni, Gianluca ^c   Rossetti, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Intraocular pressure; Long term phasing; Progressive glaucoma; Short term phasing; Visual field

Indexed keywords

AGED; ARTICLE; CENTRAL CORNEAL THICKNESS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PROSPECTIVE STUDY; VISUAL SYSTEM PARAMETERS; ADULT; OUTCOME ASSESSMENT; PERIMETRY; PROGRESSIVE OPEN ANGLE GLAUCOMA; SCOTOMA; STABLE OPEN ANGLE GLAUCOMA; VISUAL FIELD DEFECT;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TONOMETRY, OCULAR; VISUAL ACUITY; VISUAL FIELDS;

EID: 84883337101     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000351647     Document Type: Article

References (37)

1. The AGIS Investigators: The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429-440.
2. Higginbotham EJ, Gordon MO, Beiser JA, et al: The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol 2004; 122: 813-820.
3. Leske MC, Heijl A, Hussein M, et al, Early Manifest Glaucoma Trial Group: Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121: 48-56.
4. Lichter PR, Musch DC, Gillespie BW, et al: Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108: 1943-1953.
5. Fogagnolo P, Orzalesi N, Ferreras A, et al: The circadian curve of intraocular pressure: can we estimate its characteristics during office hours? Invest Ophthalmol Vis Sci 2009; 50: 2209-2215.
6. Figus M, Lazzeri S, Nardi M, Bartolomei MP, Ferreras A, Fogagnolo P: Short-term changes in the optic nerve head and visual field after trabeculectomy. Eye (Lond) 2011; 25: 1057- 1063.
7. Fogagnolo P, McNaught A, Centofanti M, Rossetti L, Orzalesi N: The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes. Invest Ophthalmol Vis Sci 2007; 48: 4557-4563.
8. Caprioli J: Intraocular pressure fluctuation: an independent risk factor for glaucoma? Arch Ophthalmol 2007; 125: 1124-1125.
9. Musch DC, Gillespie BW, Niziol LM, et al: Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2011; 118: 1766-1773.
10. De Moraes CG, Juthani VJ, Liebmann JM, et al: Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol 2011; 129: 562-568.
11. Bengtsson B, Leske MC, Hyman L, et al: Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007; 114: 205-209.
12. Bergeå B, Bodin L, Svedbergh B: Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 1999; 106: 997-1004.
13. Bhorade AM, Gordon MO, Wilson B, et al: Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study. Ophthalmology 2009; 116: 717-724.
14. Medeiros FA, Weinreb RN, Zangwill LM, et al: Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology 2008; 115: 934-940.
15. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al: Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004; 111: 1627-1635.
16. Asrani S, Zeimer R, Wilensky J, et al: Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000; 9: 134-142.
17. Orzalesi N, Rossetti L, Invernizzi T, et al: Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000; 41: 2566-2573.
18. Fogagnolo P, Rossetti L, Mazzolani F, et al: Circadian variations in central corneal thickness and intraocular pressure in patients with glaucoma. Br J Ophthalmol 2006; 90: 24-28.
19. Fogagnolo P, Capizzi F, Orzalesi N, Figus M, Ferreras A, Rossetti L: Can mean central corneal thickness and its 24-hour fluctuation influence fluctuation of intraocular pressure? J Glaucoma 2010; 19: 418-423.
20. Orzalesi N, Rossetti L, Bottoli A, Fumagalli E, Fogagnolo P: The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Arch Ophthalmol 2003; 121: 453-457.
21. Orzalesi N, Rossetti L, Bottoli A, et al: Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 2006; 113: 239-246.
22. Quaranta L, Konstas AG, Rossetti L, et al: Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) 2010; 24: 1252-1258.
23. Altmann DG: Practical Statistics for Medical Research. London, Chapman & Hall, 1991, pp 284-285.
24. Barkana Y, Anis S, Liebmann J, et al: Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006; 124: 793- 797.
25. Hughes E, Spry P, Diamond J: 24-Hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma 2003; 12: 232-236.
26. Tajunisah I, Reddy SC, Fathilah J: Diurnal variation of intraocular pressure in suspected glaucoma patients and their outcome. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1851-1857.
27. Nakakura S, Nomura Y, Ataka S, et al: Relation between office intraocular pressure and 24- hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops. J Glaucoma 2007; 16: 201-204.
28. Caprioli J, Coleman AL: Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology 2008; 115: 1123-1129.
29. Caprioli J, Varma R: Intraocular pressure: modulation as treatment for glaucoma. Am J Ophthalmol 2011; 152: 340-344.
30. Ferreras A, Pablo LE, Garway-Heath DF, Fogagnolo P, García-Feijoo J: Mapping standard automated perimetry to the peripapillary retinal nerve fiber layer in glaucoma. Invest Ophthalmol Vis Sci 2008; 49: 3018-3025.
31. Fogagnolo P, Mazzolani F, Rossetti L, Orzalesi N: Detecting glaucoma with frequencydoubling technology perimetry: a comparison between N-30 and C-20 screening programs. J Glaucoma 2005; 14: 485-491.
32. Fogagnolo P, Rossetti L, Ranno S, Ferreras A, Orzalesi N: Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma. Prog Brain Res 2008; 173: 101-124.
33. Oddone F, Centofanti M, Rossetti L, et al: Exploring the Heidelberg Retinal Tomograph 3 diagnostic accuracy across disc sizes and glaucoma stages: a multicenter study. Ophthalmology 2008; 115: 1358-1365.
34. Oddone F, Centofanti M, Iester M, et al: Sector- based analysis with the Heidelberg Retinal Tomograph 3 across disc sizes and glaucoma stages: a multicenter study. Ophthalmology 2009; 116: 1106-1111.
35. Pablo LE, Ferreras A, Pajarín AB, Fogagnolo P: Diagnostic ability of a linear discriminant function for optic nerve head parameters measured with optical coherence tomography for perimetric glaucoma. Eye (Lond) 2010; 24: 1051- 1057.
36. Pablo LE, Ferreras A, Fogagnolo P, Figus M, Pajarin AB: Optic nerve head changes in early glaucoma: a comparison between stereophotography and Heidelberg retina tomography. Eye (Lond) 2010; 24: 123-130.
37. Fogagnolo P, Rossetti L: Medical treatment of glaucoma: present and future. Expert Opin Investig Drugs 2011; 20: 947-959.